Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1998-03-27
2001-10-30
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S006120, C435S005000, C435S004000, C435S007900, C435S007250, C435S070100, C435S091200, C436S533000, C436S176000, C436S177000, C436S811000, C436S017000, C436S008000, C436S063000, C424S052000, C422S051000, C536S022100
Reexamination Certificate
active
06309827
ABSTRACT:
FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT
Not Applicable
BACKGROUND OF THE INVENTION
Currently, most analyte and DNA diagnostic assays are blood-based. Blood-based testing is invasive and poses a significant safety hazard. An alternate procedure, collecting lymph fluid, often involves surgically draining or removing lymph nodes. Collecting vaginal, rectal and nasal fluids is inconvenient and can be uncomfortable and embarrassing for both the medical professional and the patient. In contrast, the collection of oral fluid including saliva and/or mucosal transudate for testing entails minimal invasion of privacy, is convenient, relatively safe, and can be accomplished rapidly with ease. In addition, in patients where only small volumes of blood can be drawn, for example, newborns and the elderly, adequate volumes for testing can be obtained from saliva or mucosal transudate.
The idea for using oral fluid in a detection method has been discussed in scientific and clinical research for some time. Researchers have investigated using oral fluid as a possible clinical specimen for diagnosis of specific disease states or altered metabolic activity (see, e.g.,
Ann. New York Acad. Sci.,
Vol 694
: Saliva as a Diagnostic Fluid
, Malamud and Tabak, eds., N.Y. Acad. Sci. Pub. (1993)). Moreover, studies have shown that antibodies have been detected in saliva samples (Archibald et al.
J Clin Micro.
24:873-875 (1986); Parry et al.
Lancet
2:72-75 (1987)).
A number of enzyme immunoassay (EIA) kits are currently available for the screening of serum (blood) specimens for antibodies. An FDA approved EIA kit is also available specifically for screening oral fluid specimens (in particular oral fluid specimens collected using the OraSure® HIV-1 oral specimen collection device).
Detection of nucleic acid sequences in oral fluids by polymerase chain reaction (PCR) amplification and then visualization through agarose gel electrophoresis or blotting techniques has also been described (see, e.g., Irwin, et al,
Nature Biotechnology
14:1146-8 (1996); Richards, et al.,
Human Molecular Genetics
2(2):159-63 (1993)). However, the literature describes using saliva or buccal cells from scraping or brushing the inside of the cheek.
The simultaneous collection of an oral fluid sample which is the basis of diagnostic and genomic assays has never been described. Simultaneous collection would be useful when screening assay results must be confirmed in another type of assay, i.e., an HIV test. Simultaneous collection would also be useful to diagnose two or more different pathological conditions by different assays. Instead of having to collect two samples of biological fluid; the investigator could collect one sample and run the necessary assays on that sample. Finally, simultaneous collection by a single device would be useful for the detection of genetic markers demonstrating a predisposition to a certain disease and the detection of the diagnostic markers indicating the presence of that disease.
In the present invention, a bibulous pad is used to collect oral fluids. This technique has proven to be better than the methods described in the prior art which involve collecting cells with buccal brushes and swabs (Richards, et al., supra) which can be painful and oral rinses with distilled water or saline (Irwin, et al., supra). Both of these methods produce a lower yield of nucleic acids and nucleic acids of lower quality than the methods and systems claimed below.
In the present invention, an absorbent pad is contacted with oral fluid. The fluid is expressed from the pad and assayed for the presence of diagnostic marker, including immunological markers and drug and drug metabolites. A surprisingly pure and stable preparation of genomic DNA is then extracted from the pad. The exceptional purity of the DNA is not fully understood but may be due to the preservative solution used to store the pad or the pad may preferentially bind DNA or cells which contain the genomic DNA.
SUMMARY OF THE INVENTION
This invention provides for a rapid and convenient method of simultaneous collection of both genomic and diagnostic information from a single sample on a bibulous pad by differential extraction of the diagnostic information from the genomic information. The diagnostic information is physically extracted from the pad on which the genomic information remains. The genomic information is released from the pad under conditions suitable to lyse whole cells and release genomic DNA from the bibulous pad. It is a surprising discovery of this invention that a PCR assay on the contents of the bibulous pad provides results comparable in reliability, specificity, and sensitivity to the best available serum (blood) based assays.
The solution used to release the genomic information comprises a low concentration of buffer salts with buffering capacity of pH 6-9, a chelating agent, a non-ionic detergent, an antimicrobial agent and a proteinase. Alternatively, chaotropic agents may be used to release the genomic information or the nucleic acids can be separated from the pads by mechanical means, including sonication or shearing.
The assays of this invention can be used to confirm each other, either by detecting the genomic information leading to the diagnostic information, or by detecting in the genomic information, a predisposition to a disease and confirming the presence of the disease through diagnostic testing.
This invention also encompasses a system for differentially extracting diagnostic information from genomic information from the same bibulous pad. Preferably, the system incorporates an identification system so the extracts are identified as originating from the same source. The system can be incorporated into a kit with instructions for use. The kit optionally comprises means for holding the extracts. Preferably the means is sealable so a chain of custody from source of the biological fluid to practitioner assaying the fluid is established.
REFERENCES:
patent: 4752448 (1988-06-01), Wells et al.
patent: 4921787 (1990-05-01), Riggin et al.
patent: 5022409 (1991-06-01), Goldstein et al.
patent: 5059654 (1991-10-01), Hou et al.
patent: 5103836 (1992-04-01), Goldstein et al.
patent: 5112758 (1992-05-01), Fellman et al.
patent: 5120643 (1992-06-01), Ching et al.
patent: 5188968 (1993-02-01), Kano et al.
patent: 5209904 (1993-05-01), Forney et al.
patent: 5234001 (1993-08-01), Goldstein et al.
patent: 5335673 (1994-08-01), Goldstein et al.
patent: 5339829 (1994-08-01), Thieme et al.
patent: 5413913 (1995-05-01), Hillyard et al.
patent: 5479937 (1996-01-01), Thieme et al.
patent: 0 323 605 B1 (1988-12-01), None
patent: 0 591 914 (1994-04-01), None
patent: 2204398A (1988-11-01), None
patent: WO 91/13355 (1991-09-01), None
patent: WO 92/16842 (1992-10-01), None
patent: WO 93/08474 (1993-04-01), None
H. A. John, et al., “RNA-DNA hybrids at the cytological level,”Nature223:582-587 (Aug. 9, 1969).
Margaret L.M. Anderson, et al., “Quantitative Filter Hybridisation,” Chapter 4:73-111, B.D. Hames, et al.,Nucleic Acid Hybridization, IRL Press, Oxford, 1985.
David W. Archibald, et al., “Salivary antibodies as a means of detecting human T cell lymphotrophic virus type III/lymphadenopathy-associated virus infection,”J. Clin. Micro. 24(5) :873-875 (Nov. 1986).
J. V. Parry, et al., “Sensitive assays for viral antibodies in saliva: an alternative to tests on serum,”The Lancet:72-75, Jul. 11, 1987.
Edward J. Cone, et al., “Saliva as a diagnostic fluid,” 694:91-127, Presented at the N.Y. Acad. Sciences, Oct. 22, 1992-Oct. 25, 1992.
John V. Parry, “Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance,” 694:216-233,Saliva As A Diagnostic Fluid, Ann. New York Acad. Sci., Malamud and Tabak, eds., N.Y. Acad. Sci. Pub. (1993).
Brenda Richard, et al., “Multiplex PCR amplification from the CFTR gene using DNA preprared from buccal brushes/swabs,”Human Molecular Genetics2(2) :159-163 (1993).
Michael H. Irwin, et al., “Identificationof transgenic mice by PCR analysis of saliva,”Nature Biotechnology14:1146-1148
Bestwick Richard K.
Goldstein Andrew S.
Carlson Karen Cochrane
OraSure Technologies, Inc.
Robinson Hope A.
Townsend and Townsend / and Crew LLP
LandOfFree
Simultaneous collection of DNA and non-nucleic analytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Simultaneous collection of DNA and non-nucleic analytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Simultaneous collection of DNA and non-nucleic analytes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2576685